proactiveinvestors – 08 Jan 2019
“Phoenix Molecular Designs CEO Sandi Dunn joined Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.
The Vancouver-based company focuses on treating triple negative breast cancer, one of the most aggressive types of breast cancer with few treatment options.